Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 55:S16-S23, 2006
DOI: 10.2337/db06-S003
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nolan, C. J.
Right arrow Articles by Prentki, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nolan, C. J.
Right arrow Articles by Prentki, M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Section I: The Adipocyte Connection

Fatty Acid Signaling in the ß-Cell and Insulin Secretion

Christopher J. Nolan1, Murthy S.R. Madiraju2, Viviane Delghingaro-Augusto2, Marie-Line Peyot2, and Marc Prentki2

1 Department of Endocrinology, The Canberra Hospital, and the Medical School, The Australian National University, Garran, Australia
2 Molecular Nutrition Unit and the Montreal Diabetes Research Center, University of Montreal, and the Centre Hospitalier de l’Université de Montréal, Montreal, Quebec, Canada

Address correspondence and reprint requests to Marc Prentki, CR-CHUM, Pavillon de Sève Y-4603, 1560 Sherbrooke Est, Montreal, Quebec H2L 4M1, Canada. E-mail: marc.prentki{at}umontreal.ca

Abbreviations: AA, arachidonic acid; AMPK, AMP-activated protein kinase; CPT, carnitine palmitoyl-transferase; DAG, diacylglycerol; FA, fatty acid; FFA, free fatty acid; FFAR, free fatty acid receptor; GSIS, glucose-stimulated insulin secretion; HSL, hormone-sensitive lipase; iPLA2, calcium-independent ATP-stimulated phospholipase A2; KATP channel, ATP-sensitive K+ channel; LC-CoA, long-chain acyl-CoA; MCD, malonyl-CoA decarboxylase; RNAi, RNA interference; TG, triglyceride

Fatty acids (FAs) and other lipid molecules are important for many cellular functions, including vesicle exocytosis. For the pancreatic ß-cell, while the presence of some FAs is essential for glucose-stimulated insulin secretion, FAs have enormous capacity to amplify glucose-stimulated insulin secretion, which is particularly operative in situations of ß-cell compensation for insulin resistance. In this review, we propose that FAs do this via three interdependent processes, which we have assigned to a "trident model" of ß-cell lipid signaling. The first two arms of the model implicate intracellular metabolism of FAs, whereas the third is related to membrane free fatty acid receptor (FFAR) activation. The first arm involves the AMP-activated protein kinase/malonyl-CoA/long-chain acyl-CoA (LC-CoA) signaling network in which glucose, together with other anaplerotic fuels, increases cytosolic malonyl-CoA, which inhibits FA partitioning into oxidation, thus increasing the availability of LC-CoA for signaling purposes. The second involves glucose-responsive triglyceride (TG)/free fatty acid (FFA) cycling. In this pathway, glucose promotes LC-CoA esterification to complex lipids such as TG and diacylglycerol, concomitant with glucose stimulation of lipolysis of the esterification products, with renewal of the intracellular FFA pool for reactivation to LC-CoA. The third arm involves FFA stimulation of the G-protein–coupled receptor GPR40/FFAR1, which results in enhancement of glucose-stimulated accumulation of cytosolic Ca2+ and consequently insulin secretion. It is possible that FFA released by the lipolysis arm of TG/FFA cycling is partly "secreted" and, via an autocrine/paracrine mechanism, is additive to exogenous FFAs in activating the FFAR1 pathway. Glucose-stimulated release of arachidonic acid from phospholipids by calcium-independent phospholipase A2 and/or from TG/FFA cycling may also be involved. Improved knowledge of lipid signaling in the ß-cell will allow a better understanding of the mechanisms of ß-cell compensation and failure in diabetes.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. W. Joseph, M. L. Odegaard, S. M. Ronnebaum, S. C. Burgess, J. Muehlbauer, A. D. Sherry, and C. B. Newgard
Normal Flux through ATP-Citrate Lyase or Fatty Acid Synthase Is Not Required for Glucose-stimulated Insulin Secretion
J. Biol. Chem., October 26, 2007; 282(43): 31592 - 31600.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. S. Sum, I. G. Tikhonova, S. Neumann, S. Engel, B. M. Raaka, S. Costanzi, and M. C. Gershengorn
Identification of Residues Important for Agonist Recognition and Activation in GPR40
J. Biol. Chem., October 5, 2007; 282(40): 29248 - 29255.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
A. Kiely, N. H McClenaghan, P. R Flatt, and P. Newsholme
Pro-inflammatory cytokines increase glucose, alanine and triacylglycerol utilization but inhibit insulin secretion in a clonal pancreatic {beta}-cell line
J. Endocrinol., October 1, 2007; 195(1): 113 - 123.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.